Status:
COMPLETED
Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention
Lead Sponsor:
University of Colorado, Boulder
Collaborating Sponsors:
Rocky Mountain Cancer Centers
University of Colorado, Denver
Conditions:
Depression, Anxiety
Metastatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Adults diagnosed with metastatic cancer commonly experience depression and anxiety symptoms, which can interfere with advance care planning. This randomized clinical trial evaluates a novel, piloted, ...
Detailed Description
This study will evaluate an innovative, multi-modal palliative care intervention that addresses the lack of advance care planning (ACP) and unmet psychosocial needs commonly experienced by patients wi...
Eligibility Criteria
Inclusion
- At least 18 years of age
- English-speaking (able to speak, read, and write well in English)
- Diagnosed with Stage IV metastatic cancer of any solid tumor type
- Capable at time of consent of understanding and voluntarily consenting themselves to the study, attending group sessions, and completing the online sessions at home, confirmed by an Eastern Cooperative Group Performance Status Scale of 0 to 2
- Endorse moderate to severe anxiety or depression symptoms on the Patient Health Questionnaire-4
Exclusion
- Current high suicide risk
- Psychiatric hospitalization or suicide attempt in the past 5 years
- History of chronic, untreated trauma unrelated to their cancer
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04773639
Start Date
January 11 2021
End Date
January 31 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rocky Mountain Cancer Centers
Boulder, Colorado, United States, 80303